Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWhitbread Regulatory News (WTB)

Share Price Information for Whitbread (WTB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,063.00
Bid: 3,049.00
Ask: 3,051.00
Change: 36.00 (1.19%)
Spread: 2.00 (0.066%)
Open: 3,049.00
High: 3,075.00
Low: 3,034.00
Prev. Close: 3,027.00
WTB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Repurchase Programme

26 Jan 2024 07:00

RNS Number : 9738A
Whitbread PLC
26 January 2024
 

 

 

 

SHARE REPURCHASE PROGRAMME

 

 

Further to the announcement made on 18 October 2023, regarding the launch of a share buy-back programme of up to £300 million (the 'Programme'), Whitbread PLC ('Whitbread' or the 'Company') announces that it has agreed with J.P. Morgan Securities plc ('JPMS'), to extend the engagement period for the buy-back, such that the Programme will end no later than 24 April 2024.

 

JPMS shall continue to make a simultaneous on-sale of Ordinary Shares of 76 122/153 pence each ('Ordinary Shares') purchased under the instructions to Whitbread. JPMS will make their trading decisions in relation to the Programme independently of, and uninfluenced by the Company.

 

The maximum number of Ordinary Shares that can be purchased under the Programme is 14,138,162 Ordinary Shares (based on authority granted at Whitbread's 2023 Annual General Meeting). The purpose of the Programme is to reduce the share capital of the Company. Ordinary Shares purchased under the Programme will be cancelled or (to the extent permitted by law) held in treasury. The number of Shares acquired to date under the Programme is 7,274,357 for a total consideration of £243.3m.

 

Any purchase of Ordinary Shares made by JPMS in relation to the Programme will be carried out on the London Stock Exchange plc, Cboe Europe Limited or Aquis Stock Exchange Limited. The buy-back by Whitbread will be executed in accordance with the Listing Rules and Whitbread's general authority (from time to time) to make market purchases of Ordinary Shares. The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures. Whitbread will announce any purchase by it of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

JPMS may undertake transactions in shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the period of the Programme in order to manage their market exposure under the Programme. Disclosure of such transactions will not be made by JPMS as a result of or as part of the Programme, but JPMS will continue to make any disclosures they are otherwise legally required to make.

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For more information please contact:

Investor Relations - Whitbread investorrelations@whitbread.com

 

Media - Teneo whitbread@teneo.com

Jessica Reid +44 (0) 20 7353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAXFSALALEFA
Date   Source Headline
1st Aug 202211:00 amRNSTotal Voting Rights
25th Jul 20229:07 amRNSBlock listing Interim Review
21st Jul 20227:10 amRNSDirector Declaration
11th Jul 20221:39 pmRNSDirector/PDMR Shareholding
1st Jul 20223:43 pmRNSDirector/PDMR Shareholding
29th Jun 202210:15 amRNSDirectorate Change
17th Jun 20223:56 pmRNSHolding(s) in Company
15th Jun 20225:24 pmRNSResult of AGM
15th Jun 20227:00 amRNSQ1 Trading Update
10th Jun 20229:59 amRNSHolding(s) in Company
1st Jun 20224:52 pmRNSTotal Voting Rights
27th May 20224:33 pmRNSDirector/PDMR Shareholding
24th May 20224:08 pmRNSDirector/PDMR Shareholding
13th May 20221:39 pmRNSDirector/PDMR Shareholding
12th May 20224:57 pmRNSNotice of AGM
28th Apr 20224:02 pmRNSDirector/PDMR Shareholding
28th Apr 20227:00 amRNSPreliminary Results Announcement
1st Apr 202212:40 pmRNSTotal Voting Rights
7th Mar 20223:57 pmRNSDirector/PDMR Shareholding
2nd Mar 20222:46 pmRNSTotal Voting Rights
1st Feb 20229:11 amRNSTotal Voting Rights
27th Jan 20227:00 amRNSDirectorate Change
25th Jan 20229:57 amRNSBlock listing Interim Review
12th Jan 20227:00 amRNSQ3 FY22 Trading Update
4th Jan 20229:08 amRNSTotal Voting Rights
23rd Dec 202111:34 amRNSDirector/PDMR Shareholding
17th Dec 20214:59 pmRNSAGM Statement
1st Dec 202110:01 amRNSTotal Voting Rights
23rd Nov 20213:31 pmRNSDirector/PDMR Shareholding
8th Nov 20211:18 pmRNSDirector/PDMR Shareholding
1st Nov 20213:14 pmRNSTotal Voting Rights
28th Oct 20214:40 pmRNSDirector/PDMR Shareholding
28th Oct 20213:45 pmRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSWhitbread Interim Results
15th Oct 202112:15 pmRNSDirectorate Change
1st Oct 202110:07 amRNSTotal Voting Rights
1st Sep 20214:45 pmRNSS430 (2B) Companies Act 2006 Statement
1st Sep 20214:41 pmRNSTotal Voting Rights
17th Aug 20217:48 amRNSDirector Declaration
11th Aug 20214:28 pmRNSDirector/PDMR Shareholding
9th Aug 20214:32 pmRNSDirector/PDMR Shareholding
6th Aug 20219:56 amRNSTotal Voting Rights
2nd Aug 20213:20 pmRNSDirector/PDMR Shareholding
26th Jul 20219:17 amRNSBlock listing Interim Review
1st Jul 20213:55 pmRNSDirector/PDMR Shareholding
1st Jul 20213:52 pmRNSTotal Voting Rights
25th Jun 202111:54 amRNSDirector/PDMR Shareholding
18th Jun 202112:09 pmRNSDirector/PDMR Shareholding
17th Jun 20214:36 pmRNSAGM Statement
17th Jun 20217:00 amRNSQ1 FY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.